Strides Pharma Science Reaches All-Time High, Recognized by MarketsMOJO for Strong Performance

Strides Pharma Science, a midcap pharmaceutical company, has recently reached an all-time high in its stock price on October 11, 2024. The stock is currently trading at Rs 1525, which is 1.45% away from its 52-week high of Rs 1547.15. This performance has been recognized by MarketsMOJO, a leading stock market analysis platform, which has given a 'Hold' rating for the stock.

Strides Pharma Science has been a part of the Momentumnow Stocks on MarketsMOJO since April 3, 2024. The stock has shown consistent growth, outperforming the sector by 0.79%. In the last 4 days, the stock has gained 8.01% returns, indicating a consecutive upward trend. The stock has been trading at a steady price of 1525 since its opening.

The moving averages for Strides Pharma Science are also positive, with the stock trading higher than the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a strong performance and potential for further growth.

In comparison to the Sensex, Strides Pharma Science has shown an impressive 1-year performance of 206.41%, while the Sensex has only grown by 22.57%. This showcases the company's strong position in the pharmaceutical industry and its ability to generate significant returns for investors.

Overall, Strides Pharma Science has shown a promising performance in the stock market, with its recent all-time high and consistent growth. With a 'Hold' rating from MarketsMOJO and positive moving averages, the stock is definitely one to watch in the midcap pharmaceutical sector.